Found: 223
Select item for more details and to access through your institution.
Change in PD-L1 Expression After Acquiring Resistance to Gefitinib in EGFR-Mutant Non-Small-Cell Lung Cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Biomarker-driven phase 2 umbrella trial study for patients with recurrent small cell lung cancer failing platinum-based chemotherapy.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Genomic landscape of acquired resistance to third-generation EGFR tyrosine kinase inhibitors in EGFR T790M-mutant non-small cell lung cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Clinical trial of nintedanib in patients with recurrent or metastatic salivary gland cancer of the head and neck: A multicenter phase 2 study (Korean Cancer Study Group HN14-01).
- Published in:
- 2017
- By:
- Publication type:
- journal article
A Korean multi-center, real-world, retrospective study of first-line pazopanib in unselected patients with metastatic renal clear-cell carcinoma.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Clinical application of genomic profiling to find druggable targets for adolescent and young adult (AYA) cancer patients with metastasis.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Characterization of genetic aberrations in a single case of metastatic thymic adenocarcinoma.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Dissecting transcriptome signals of anti-PD-1 response in lung adenocarcinoma.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-72108-5
- By:
- Publication type:
- Article
ERK inhibitor ASN007 effectively overcomes acquired resistance to EGFR inhibitor in non‐small cell lung cancer.
- Published in:
- Investigational New Drugs, 2022, v. 40, n. 2, p. 265, doi. 10.1007/s10637-021-01121-6
- By:
- Publication type:
- Article
Entrectinib resistance mechanisms in ROS1-rearranged non-small cell lung cancer.
- Published in:
- Investigational New Drugs, 2020, v. 38, n. 2, p. 360, doi. 10.1007/s10637-019-00795-3
- By:
- Publication type:
- Article
AZD9291 overcomes T790 M-mediated resistance through degradation of EGFR in non-small cell lung cancer cells.
- Published in:
- Investigational New Drugs, 2016, v. 34, n. 4, p. 407, doi. 10.1007/s10637-016-0350-y
- By:
- Publication type:
- Article
Arsenic trioxide represses constitutive activation of NF-?B and COX-2 expression in human acute myeloid leukemia, HL-60.
- Published in:
- Journal of Cellular Biochemistry, 2005, v. 94, n. 4, p. 695, doi. 10.1002/jcb.20337
- By:
- Publication type:
- Article
Surrogate decision-making in Korean patients with advanced cancer: a longitudinal study.
- Published in:
- Supportive Care in Cancer, 2013, v. 21, n. 1, p. 183, doi. 10.1007/s00520-012-1509-5
- By:
- Publication type:
- Article
Association of oral mucositis with quality of life and symptom clusters in patients with solid tumors receiving chemotherapy.
- Published in:
- Supportive Care in Cancer, 2012, v. 20, n. 2, p. 395, doi. 10.1007/s00520-011-1126-8
- By:
- Publication type:
- Article
Behavioral risk factors and use of preventive screening services among spousal caregivers of cancer patients.
- Published in:
- 2011
- By:
- Publication type:
- journal article
IDH2 mutation in gliomas including novel mutation.
- Published in:
- Neuropathology, 2015, v. 35, n. 3, p. 236, doi. 10.1111/neup.12187
- By:
- Publication type:
- Article
Methylation status of the MGMT gene promoter fails to predict the clinical outcome of glioblastoma patients treated with ACNU plus cisplatin.
- Published in:
- Neuropathology, 2009, v. 29, n. 4, p. 443, doi. 10.1111/j.1440-1789.2008.00998.x
- By:
- Publication type:
- Article
Transformation of Nonfunctioning Pancreatic Neuroendocrine Carcinoma Cells into Insulin Producing Cells after Treatment with Sunitinib.
- Published in:
- 2013
- By:
- Publication type:
- Case Study
First-Line Alectinib vs. Brigatinib in Advanced Non-Small Cell Lung Cancer with ALK Rearrangement: Real-World Data.
- Published in:
- Cancer Research & Treatment, 2024, v. 56, n. 1, p. 61, doi. 10.4143/crt.2023.461
- By:
- Publication type:
- Article
Expanded Access Program Pralsetinib in Advanced Non-Small Cell Lung Cancer with Rearranged during Transfection (RET) Gene Rearrangement.
- Published in:
- Cancer Research & Treatment, 2023, v. 55, n. 4, p. 1144, doi. 10.4143/crt.2023.403
- By:
- Publication type:
- Article
Phase II Trial of Combined Durvalumab Plus Tremelimumab with Proton Therapy for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma.
- Published in:
- Cancer Research & Treatment, 2023, v. 55, n. 4, p. 1104, doi. 10.4143/crt.2023.502
- By:
- Publication type:
- Article
EGFR Mutation-Positive Unresectable Stage III Non-Squamous Lung Cancer Is Associated with a High Incidence of Brain Metastasis.
- Published in:
- Cancer Research & Treatment, 2023, v. 55, n. 2, p. 498, doi. 10.4143/crt.2022.388
- By:
- Publication type:
- Article
The Role of Brain Radiotherapy before First-Line Afatinib Therapy, Compared to Gefitinib or Erlotinib, in Patients with EGFR-Mutant Non-Small Cell Lung Cancer.
- Published in:
- Cancer Research & Treatment, 2023, v. 55, n. 2, p. 479, doi. 10.4143/crt.2022.1344
- By:
- Publication type:
- Article
Cancer-Specific Sequences in the Diagnosis and Treatment of NUT Carcinoma.
- Published in:
- Cancer Research & Treatment, 2023, v. 55, n. 2, p. 452, doi. 10.4143/crt.2022.910
- By:
- Publication type:
- Article
Osimertinib Combined with Systemic Chemotherapy for EGFR Mutant, T790M-Negative, Non–Small Cell Lung Cancer Patients Who Develop Leptomeningeal Metastases with Extracranial Progression to Prior EGFR TKI.
- Published in:
- Cancer Research & Treatment, 2023, v. 55, n. 1, p. 344, doi. 10.4143/crt.2021.1603
- By:
- Publication type:
- Article
A Single-Arm, Prospective, Phase II Study of Cisplatin Plus Weekly Docetaxel as First-Line Therapy in Patients with Metastatic or Recurrent Salivary Gland Cancer.
- Published in:
- Cancer Research & Treatment, 2022, v. 54, n. 3, p. 719, doi. 10.4143/crt.2021.1019
- By:
- Publication type:
- Article
Long-term Survival in Non-Small Cell Lung Cancer Patients with Metachronous Brain-Only Oligorecurrence Who Underwent Definitive Treatment.
- Published in:
- Cancer Research & Treatment, 2022, v. 54, n. 1, p. 150, doi. 10.4143/crt.2021.306
- By:
- Publication type:
- Article
EGFR C797S as a Resistance Mechanism of Lazertinib in Non-small Cell Lung Cancer with EGFR T790M Mutation.
- Published in:
- Cancer Research & Treatment, 2020, v. 52, n. 4, p. 1288, doi. 10.4143/crt.2020.278
- By:
- Publication type:
- Article
Clinical Characteristics and Outcomes of Non-small Cell Lung Cancer Patients with HER2 Alterations in Korea.
- Published in:
- Cancer Research & Treatment, 2020, v. 52, n. 1, p. 292, doi. 10.4143/crt.2019.186
- By:
- Publication type:
- Article
Clinical Outcomes of EGFR Exon 20 Insertion Mutations in Advanced Non-small Cell Lung Cancer in Korea.
- Published in:
- Cancer Research & Treatment, 2019, v. 51, n. 2, p. 623, doi. 10.4143/crt.2018.151
- By:
- Publication type:
- Article
Efficacy and Safety of Afatinib for EGFR-mutant Non-small Cell Lung Cancer, Compared with Gefitinib or Erlotinib.
- Published in:
- Cancer Research & Treatment, 2019, v. 51, n. 2, p. 502, doi. 10.4143/crt.2018.117
- By:
- Publication type:
- Article
EGFR Mutation Is Associated with Short Progression-Free Survival in Patients with Stage III Non-squamous Cell Lung Cancer Treated with Concurrent Chemoradiotherapy.
- Published in:
- Cancer Research & Treatment, 2019, v. 51, n. 2, p. 493, doi. 10.4143/crt.2018.125
- By:
- Publication type:
- Article
Landscape of Actionable Genetic Alterations Profiled from 1,071 Tumor Samples in Korean Cancer Patients.
- Published in:
- Cancer Research & Treatment, 2019, v. 51, n. 1, p. 211, doi. 10.4143/crt.2018.132
- By:
- Publication type:
- Article
Rare Mechanism of Acquired Resistance to Osimertinib in Korean Patients with EGFR-Mutated Non-small Cell Lung Cancer.
- Published in:
- Cancer Research & Treatment, 2019, v. 51, n. 1, p. 408, doi. 10.4143/crt.2018.138
- By:
- Publication type:
- Article
Open Access Pazopanib for the Treatment of Non-clear Cell Renal Cell Carcinoma: A Single-Arm, Open-Label, Multicenter, Phase II Study.
- Published in:
- Cancer Research & Treatment, 2018, v. 50, n. 2, p. 488, doi. 10.4143/crt.2016.584
- By:
- Publication type:
- Article
Genetic Alterations and Their Clinical Implications in High-Recurrence Risk Papillary Thyroid Cancer.
- Published in:
- Cancer Research & Treatment, 2017, v. 49, n. 4, p. 906, doi. 10.4143/crt.2016.424
- By:
- Publication type:
- Article
Post-bevacizumab Clinical Outcomes and the Impact of Early Discontinuation of Bevacizumab in Patients with Recurrent Malignant Glioma.
- Published in:
- Cancer Research & Treatment, 2017, v. 49, n. 1, p. 129, doi. 10.4143/crt.2015.466
- By:
- Publication type:
- Article
Association between PD-L1 and HPV Status and the Prognostic Value of PD-L1 in Oropharyngeal Squamous Cell Carcinoma.
- Published in:
- Cancer Research & Treatment, 2016, v. 48, n. 2, p. 527, doi. 10.4143/crt.2015.249
- By:
- Publication type:
- Article
VEGF and Ki-67 Overexpression in Predicting Poor Overall Survival in Adenoid Cystic Carcinoma.
- Published in:
- Cancer Research & Treatment, 2016, v. 48, n. 2, p. 518, doi. 10.4143/crt.2015.093
- By:
- Publication type:
- Article
Reduced Dose Intensities of Doxorubicin in Elderly Patients with DLBCL in Rituximab Era.
- Published in:
- Cancer Research & Treatment, 2016, v. 48, n. 1, p. 304, doi. 10.4143/crt.2014.339
- By:
- Publication type:
- Article
Gefitinib-Induced Interstitial Lung Disease in Korean Lung Cancer Patients.
- Published in:
- Cancer Research & Treatment, 2016, v. 48, n. 1, p. 88, doi. 10.4143/crt.2014.201
- By:
- Publication type:
- Article
Phase I Study of OPB-31121, an Oral STAT3 Inhibitor, in Patients with Advanced Solid Tumors.
- Published in:
- Cancer Research & Treatment, 2015, v. 47, n. 4, p. 607, doi. 10.4143/crt.2014.249
- By:
- Publication type:
- Article
Pemetrexed Singlet Versus Nonpemetrexed-Based Platinum Doublet as Second-Line Chemotherapy after First-Line Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor Failure in Non-small Cell Lung Cancer Patients with EGFR Mutations.
- Published in:
- Cancer Research & Treatment, 2015, v. 47, n. 4, p. 630, doi. 10.4143/crt.2014.244
- By:
- Publication type:
- Article
Cancer Treatment near the End-of-Life Becomes More Aggressive: Changes in Trend during 10 Years at a Single Institute.
- Published in:
- Cancer Research & Treatment, 2015, v. 47, n. 4, p. 555, doi. 10.4143/crt.2014.200
- By:
- Publication type:
- Article
Cisplatin-Based Chemotherapy Is a Strong Risk Factor for Thromboembolic Events in Small-Cell Lung Cancer.
- Published in:
- Cancer Research & Treatment, 2015, v. 47, n. 4, p. 670, doi. 10.4143/crt.2014.045
- By:
- Publication type:
- Article
The Impact of Molecularly Targeted Treatment on Direct Medical Costs in Patients with Advanced Non-small Cell Lung Cancer.
- Published in:
- Cancer Research & Treatment, 2015, v. 47, n. 2, p. 182, doi. 10.4143/crt.2013.227
- By:
- Publication type:
- Article
Nomogram Predicting Clinical Outcomes in Non-small Cell Lung Cancer Patients Treated with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors.
- Published in:
- Cancer Research & Treatment, 2014, v. 46, n. 4, p. 323, doi. 10.4143/crt.2013.120
- By:
- Publication type:
- Article
A Phase I Study of Oral Paclitaxel with a Novel P-Glycoprotein Inhibitor, HM30181A, in Patients with Advanced Solid Cancer.
- Published in:
- Cancer Research & Treatment, 2014, v. 46, n. 3, p. 234, doi. 10.4143/crt.2014.46.3.234
- By:
- Publication type:
- Article
Low-Dose Whole Brain Radiotherapy with Tumor Bed Boost after Methotrexate-Based Chemotherapy for Primary Central Nervous System Lymphoma.
- Published in:
- Cancer Research & Treatment, 2014, v. 46, n. 3, p. 261, doi. 10.4143/crt.2014.46.3.261
- By:
- Publication type:
- Article
Clinical Implications of VEGF, TGF-ß1, and IL-1 ß in Patients with Advanced Non-small Cell Lung Cancer.
- Published in:
- Cancer Research & Treatment, 2013, v. 45, n. 4, p. 325, doi. 10.4143/crt.2013.45.4.325
- By:
- Publication type:
- Article